Swiss clinical trial patient recruitment specialist Clinerion is partnering (PDF) with Patient iP, a health data and analytics company, to improve clinical trial design, site selection and patient enrollment.
Under the terms of the deal, the two will use Clinerion’s Patient Network Explorer platform and Patient iP’s daTAscape to improve clinical trial site and speed up trail enrollment.
Clinerion uses electronic health records from a large global network of hospitals it maintains to help trial sponsors identify patients, as well as generate real-world evidence and market access analyses.
Currently, Clinerion’s network boasts more than 17 million real-time patient lives, with another 55 million lives contracted an in implementation in more than 100 hospitals in the Americas, Europe and Asia, the company said. Patient iP’s platform holds more than 16 million ambulatory electronic medical records across 5,000 practice sites.
“The creation of a network of Clinerion alliance partners establishes a new, global and comprehensive, service resource for actionable patient data insights for clinical research,” Ian Rentsch, Clinerion’s chief executive, said in a statement. “We are happy to bring the international footprint of our hospital network to the benefit of Patient iP’s clients. At the same time, this collaboration will broaden our current ability to service clients with real-world data from the United States.”
Rentsch joined Clinerion in March. Clinerion, which has been on a network expansion spree that includes a collaboration with Provisio, has said it plans to reach every continent and almost double the number of accessible patients to 310 million by the end of 2018.